001046027 001__ 1046027
001046027 005__ 20260122203303.0
001046027 0247_ $$2doi$$a10.1093/noajnl/vdaf198
001046027 0247_ $$2datacite_doi$$a10.34734/FZJ-2025-03667
001046027 037__ $$aFZJ-2025-03667
001046027 082__ $$a610
001046027 1001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b0$$eCorresponding author
001046027 245__ $$aAssessment of 18F-FET PET-based response in patients with gliomas using the PET RANO 1.0 criteria
001046027 260__ $$aOxford$$bOxford University Press$$c2025
001046027 3367_ $$2DRIVER$$aarticle
001046027 3367_ $$2DataCite$$aOutput Types/Journal article
001046027 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1769082805_22749
001046027 3367_ $$2BibTeX$$aARTICLE
001046027 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001046027 3367_ $$00$$2EndNote$$aJournal Article
001046027 520__ $$aBackgroundWe evaluated the amino acid PET-based response assessment criteria (PET RANO 1.0) for their proficiency in predicting longer survival in patients with gliomas undergoing adjuvant temozolomide chemotherapy.MethodsIn a previous study, 38 patients with newly diagnosed grade 4 gliomas according to the World Health Organisation classification underwent O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) PET at baseline and after the second cycle of adjuvant temozolomide chemotherapy. The ability of PET parameter changes to predict favorable progression-free and overall survival (PFS, OS) of ≥ 9 and ≥15 months was evaluated. Here, we performed a post-hoc analysis of these PET data to evaluate the PET RANO 1.0 criteria. In addition, the value of the RANO 2.0 criteria for MRI to predict response was evaluated and compared with the PET RANO 1.0 criteria.ResultsAccording to the PET RANO 1.0 criteria, patients with Stable Disease (n = 16), Partial Response (n = 9), or Complete Response (n = 0) had a significantly longer OS than patients with Progressive Disease (n = 13) (16.8 vs. 12.0 months; P = 0.016). This difference remained significant in the multivariate survival analysis (HR, 4.185; 95% CI, 1.715-10.530, P = 0.002). In contrast, PFS was not significantly different between the two groups (9.7 vs. 8.1 months; P = 0.147). PET RANO 1.0 criteria could not identify patients with a PFS ≥ 9 months (P = 0.503) or OS ≥ 15 months (P = 0.722). RANO 2.0 criteria for MRI was unable to predict a longer PFS (8.8 vs. 9.8 months; P = 0.565) or OS (16.4 vs. 16.8 months; P = 0.625).ConclusionsOur data suggest that PET RANO 1.0 criteria identify survival differences between predefined groups.
001046027 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001046027 588__ $$aDataset connected to DataCite
001046027 7001_ $$0P:(DE-HGF)0$$aCeccon, Garry$$b1
001046027 7001_ $$0P:(DE-Juel1)190394$$aWollring, Michael Matthias$$b2
001046027 7001_ $$0P:(DE-HGF)0$$aStetter, Isabelle$$b3
001046027 7001_ $$0P:(DE-HGF)0$$aWerner, Jan-Michael$$b4
001046027 7001_ $$0P:(DE-HGF)0$$aPeplinski, Jana-Marie$$b5
001046027 7001_ $$0P:(DE-HGF)0$$aRosen, Jurij$$b6
001046027 7001_ $$0P:(DE-HGF)0$$aRosen, Elena K.$$b7
001046027 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon Rudolf$$b8$$ufzj
001046027 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b9$$ufzj
001046027 7001_ $$0P:(DE-Juel1)145110$$aLohmann, Philipp$$b10$$ufzj
001046027 773__ $$0PERI:(DE-600)3009682-0$$a10.1093/noajnl/vdaf198$$gp. vdaf198$$n1$$pvdaf198$$tNeuro-oncology advances$$v7$$x2632-2498$$y2025
001046027 8564_ $$uhttps://juser.fz-juelich.de/record/1046027/files/Invoice_SOA25LT011306.pdf
001046027 8564_ $$uhttps://juser.fz-juelich.de/record/1046027/files/vdaf198.pdf$$yOpenAccess
001046027 8767_ $$8SOA25LT011306$$92025-09-05$$a1200217240$$d2025-09-09$$eAPC$$jZahlung erfolgt$$z2,092.00 USD
001046027 909CO $$ooai:juser.fz-juelich.de:1046027$$popenaire$$popen_access$$pOpenAPC$$pdriver$$pVDB$$popenCost$$pdnbdelivery
001046027 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b0$$kFZJ
001046027 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b8$$kFZJ
001046027 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b9$$kFZJ
001046027 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145110$$aForschungszentrum Jülich$$b10$$kFZJ
001046027 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001046027 9141_ $$y2025
001046027 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
001046027 915pc $$0PC:(DE-HGF)0003$$2APC$$aDOAJ Journal
001046027 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-18
001046027 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2024-12-18
001046027 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOL ADV : 2022$$d2024-12-18
001046027 915__ $$0LIC:(DE-HGF)CCBYNC4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial CC BY-NC 4.0
001046027 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-03T10:37:56Z
001046027 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-03T10:37:56Z
001046027 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-18
001046027 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-18
001046027 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-18
001046027 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001046027 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-03T10:37:56Z
001046027 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-18
001046027 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-18
001046027 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-18
001046027 920__ $$lyes
001046027 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
001046027 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
001046027 980__ $$ajournal
001046027 980__ $$aVDB
001046027 980__ $$aUNRESTRICTED
001046027 980__ $$aI:(DE-Juel1)INM-3-20090406
001046027 980__ $$aI:(DE-Juel1)INM-4-20090406
001046027 980__ $$aAPC
001046027 9801_ $$aAPC
001046027 9801_ $$aFullTexts